Back to Search Start Over

Changes in Transmission and Symptoms of SARS-CoV-2 in United States Households, April 2020–September 2022

Authors :
Alexandra M. Mellis
Adam S. Lauring
H. Keipp Talbot
Huong Q. McLean
Kerry Grace Morrissey
Melissa S. Stockwell
Natalie M. Bowman
Yvonne Maldonado
Katherine D. Ellingson
Suchitra Rao
Jessica E. Biddle
Sheroi Johnson
Constance Ogokeh
Phillip P. Salvatore
Carrie Reed
Sarah E. Smith-Jeffcoat
Jennifer K. Meece
Kayla E. Hanson
Edward A. Belongia
Emily E. Bendall
Julie Gilbert
Vanessa Olivo
Lori S. Merrill
Son H. McLaren
Ellen Sano
Celibell Y. Vargas
Lisa Saiman
Raul A Silverio Francisco
Ayla Bullock
Jessica Lin
Prasanthi Govindarajan
Sarah H. Goodman
Clea C. Sarnquist
Karen Lutrick
Karla I. Ledezma
Ferris A. Ramadan
Kathleen Pryor
Flavia N Miiro
Edwin Asturias
Samuel Dominguez
Daniel Olson
Hector S. Izurieta
James Chappell
Christopher Lindsell
Natasha Halasa
Kimberly Hart
Yuwei Zhu
Jonathan Schmitz
Melissa A. Rolfes
Carlos G. Grijalva
Publication Year :
2023
Publisher :
Cold Spring Harbor Laboratory, 2023.

Abstract

BackgroundThe natural history of SARS-CoV-2 infection and transmission dynamics may have changed as SARS-CoV-2 has evolved and population immunity has shifted.MethodsHousehold contacts, enrolled from two multi-site case-ascertained household transmission studies (April 2020–April 2021 and September 2021–September 2022), were followed for 10–14 days after enrollment with daily collection of nasal swabs and/or saliva for SARS-CoV-2 testing and symptom diaries. SARS-CoV-2 virus lineage was determined by whole genome sequencing, with multiple imputation where sequences could not be recovered. Adjusted infection risks were estimated using modified Poisson regression.Findings858 primary cases with 1473 household contacts were examined. Among unvaccinated household contacts, the infection risk adjusted for presence of prior infection and age was 58% (95% confidence interval [CI]: 49–68%) in households currently exposed to pre-Delta lineages and 90% (95% CI: 74–100%) among those exposed to Omicron BA.5 (detected May – September 2022). The fraction of infected household contacts reporting any symptom was similarly high between pre-Delta (86%, 95% CI: 81–91%) and Omicron lineages (77%, 70–85%). Among Omicron BA.5-infected contacts, 48% (41–56%) reported fever, 63% (56–71%) cough, 22% (17–28%) shortness of breath, and 20% (15–27%) loss of/change in taste/smell.InterpretationThe risk of infection among household contacts exposed to SARS-CoV-2 is high and increasing with more recent SARS-CoV-2 lineages. This high infection risk highlights the importance of vaccination to prevent severe disease.FundingFunded by the Centers for Disease Control and Prevention and the Food and Drug Administration.Key points-Monitoring the transmissibility and symptomatology of SARS-CoV-2 lineages is important for informing public health practice and understanding the epidemiology of COVID-19; household transmission studies contribute to our understanding of the natural history of SARS-CoV-2 infections and the transmissibility of SARS-CoV-2 variants.-The Omicron BA.5 sub-lineage is highly transmissible, similar to previous Omicron sub-lineages.-Over 80% of infected household contacts reported at least 1 symptom during their infection and the proportion of household contacts with asymptomatic infection did not differ by SARS-CoV-2 variant. The most common symptom was cough. Change in taste or smell was more common in Omicron BA.5 infections, compared to previous Omicron sub-lineages, but less common compared to pre-Delta lineages.-The high infection risk among household contacts supports the recommendations that individuals maintain up-to-date and lineage-specific vaccinations to mitigate further risks of severe disease.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........74a9ca129ffd9997f9899690d287c23d